Insulet
PODD
#1907
Rank
HK$84.95 B
Marketcap
HK$1,227
Share price
1.28%
Change (1 day)
-51.92%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): HK$3.66 Billion

According to Insulet's latest financial reports the company's current earnings are HK$2.90 Billion. In 2025 the company made an earning of HK$3.12 Billion, an increase over its 2024 earnings that were of HK$2.68 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$3.66 B17.19%
2025 HK$3.12 B16.3%
2024 HK$2.68 B36.76%
2023 HK$1.96 B481.9%
2022 HK$0.33 B-45.24%
2021 HK$0.61 B43.35%
2020 HK$0.43 B18.51%
2019 HK$0.36 B41.16%
2018 HK$0.25 B-711.95%
2017 -HK$42.01 Million-56.85%
2016 -HK$97.37 Million-79.31%
2015 -HK$0.48 Billion63.85%
2014 -HK$0.29 Billion31.04%
2013 -HK$0.22 Billion-21.96%
2012 -HK$0.29 Billion
2010 -HK$0.27 Billion-42.38%
2009 -HK$0.47 Billion-33.56%
2008 -HK$0.7 Billion65.93%
2007 -HK$0.43 Billion209.75%
2006 -HK$0.14 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$203.48 B 5,436.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$63.73 B 1,634.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$49.15 B 1,237.60%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
HK$243.79 B 6,533.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-HK$1.57 Billion-142.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
HK$0.76 B-79.18%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
HK$9.55 B 160.08%๐Ÿ‡บ๐Ÿ‡ธ USA